171 related articles for article (PubMed ID: 22149608)
1. Why is the response rate slow in ceftazidime therapy for melioidosis?
Puthucheary SD; Sam IC
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):5-7. PubMed ID: 22149608
[No Abstract] [Full Text] [Related]
2. Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion for treatment of septicaemic melioidosis.
Soontornpas C; Saraya S; Chulasiri M; Chindavijak B; Mootsikapun P
Int J Antimicrob Agents; 2005 Nov; 26(5):403-7. PubMed ID: 16216470
[TBL] [Abstract][Full Text] [Related]
3. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
4. Systemic melioidiosis.
Dias E; Dias M
Indian Pediatr; 2011 Feb; 48(2):161. PubMed ID: 21378433
[No Abstract] [Full Text] [Related]
5. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P
Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628
[TBL] [Abstract][Full Text] [Related]
6. Endophthalmitis: potential benefits of repeated intravitreal injections of antibiotics.
Hui M; Lam WH; Ho WH; Chan CY
J Clin Microbiol; 2008 Apr; 46(4):1573. PubMed ID: 18387965
[No Abstract] [Full Text] [Related]
7. Development of ceftazidime resistance in Burkhoderia pseudomallei in a patient experiencing melioidosis with mediastinal lymphadenitis.
Kung CT; Lee CH; Li CJ; Lu HI; Ko SF; Liu JW
Ann Acad Med Singap; 2010 Dec; 39(12):945-3. PubMed ID: 21274496
[No Abstract] [Full Text] [Related]
8. A role for carbapenem in the treatment of melioidosis in developing countries?
Laowansiri P; Shah S; Kiratisin P; Apisarnthanarak A
Int J Infect Dis; 2009 Sep; 13(5):e331-2. PubMed ID: 19231268
[No Abstract] [Full Text] [Related]
9. Pulmonary Delivery of Ceftazidime for the Treatment of Melioidosis in a Murine Model.
Ruiz SI; Bowen LE; Bailey MM; Berkland C
Mol Pharm; 2018 Mar; 15(3):1371-1376. PubMed ID: 29363975
[TBL] [Abstract][Full Text] [Related]
10. Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response.
Cummings JE; Slayden RA
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005209. PubMed ID: 28081127
[TBL] [Abstract][Full Text] [Related]
11. Melioidosis: advances in diagnosis and treatment.
Cheng AC
Curr Opin Infect Dis; 2010 Dec; 23(6):554-9. PubMed ID: 20847695
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime resistance in Burkholderia pseudomallei: first report from India.
Behera B; Prasad Babu TL; Kamalesh A; Reddy G
Asian Pac J Trop Med; 2012 Apr; 5(4):329-30. PubMed ID: 22449529
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Clinical Isolates of
Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
[No Abstract] [Full Text] [Related]
14. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?
Saraya S; Soontornpas C; Chindavijak B; Mootsikapun P
Indian J Med Microbiol; 2009; 27(1):88-9. PubMed ID: 19172079
[No Abstract] [Full Text] [Related]
15. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.
Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B
Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491
[TBL] [Abstract][Full Text] [Related]
16. Melioidosis of the spleen diagnosed by 16S rDNA amplification and sequencing.
Chlebicki MP; Tan BH; Koh TH
Scand J Infect Dis; 2005; 37(6-7):517-20. PubMed ID: 16012017
[TBL] [Abstract][Full Text] [Related]
17. Localized melioidosis.
Raja NS
J Pak Med Assoc; 2003 Aug; 53(8):373-4. PubMed ID: 14558747
[No Abstract] [Full Text] [Related]
18. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand.
Wuthiekanun V; Amornchai P; Saiprom N; Chantratita N; Chierakul W; Koh GC; Chaowagul W; Day NP; Limmathurotsakul D; Peacock SJ
Antimicrob Agents Chemother; 2011 Nov; 55(11):5388-91. PubMed ID: 21876049
[TBL] [Abstract][Full Text] [Related]
19. Melioidosis: antibiogram of cases in Singapore 1987-2007.
Tan AL; Tan ML
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S101-2. PubMed ID: 19121668
[TBL] [Abstract][Full Text] [Related]
20. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.
Visca P; Cazzola G; Petrucca A; Braggion C
Clin Infect Dis; 2001 Jan; 32(1):E15-6. PubMed ID: 11112669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
